These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20653645)

  • 1. Validation of a short version of the revised drug use screening inventory in a Brazilian sample of adolescents.
    Fidalgo TM; Tarter R; da Silveira ED; Kirisci L; da Silveira DX
    Am J Addict; 2010; 19(4):364-7. PubMed ID: 20653645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening current and future diagnosis of psychiatric disorders using the Revised Drug Use Screening Inventory.
    Kirisci L; Tarter R; Mezzich A; Reynolds M
    Am J Drug Alcohol Abuse; 2008; 34(5):653-65. PubMed ID: 18821459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of drug use in a teenage Brazilian sample using the Drug Use Screening Inventory (DUSI).
    De Micheli D; Formigoni ML
    Addict Behav; 2000; 25(5):683-91. PubMed ID: 11023011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance abuse and associated psychosocial risk factors among Turkish male adolescents.
    Aytaclar S; Erkiran M; Kirisci L; Tarter R
    Addict Behav; 2003 Oct; 28(8):1419-29. PubMed ID: 14512064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of identification and usefulness of the Lie Scale of the Drug Use Screening Inventory (DUSI-R) in the assessment of adolescent drug use.
    Dalla-Déa HR; De Micheli D; Formigoni ML
    Drug Alcohol Depend; 2003 Dec; 72(3):215-23. PubMed ID: 14643938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norms and sensitivity of the adolescent version of the drug use screening inventory.
    Kirisci L; Mezzich A; Tarter R
    Addict Behav; 1995; 20(2):149-57. PubMed ID: 7484309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties of the Drug Use Disorders Identification Test (DUDIT) with substance abusers in outpatient and residential treatment.
    Voluse AC; Gioia CJ; Sobell LC; Dum M; Sobell MB; Simco ER
    Addict Behav; 2012 Jan; 37(1):36-41. PubMed ID: 21937169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the Brazilian version of the drug use screening inventory.
    De Micheli D; Formigoni ML
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1523-8. PubMed ID: 12394285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients.
    Knight JR; Sherritt L; Shrier LA; Harris SK; Chang G
    Arch Pediatr Adolesc Med; 2002 Jun; 156(6):607-14. PubMed ID: 12038895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of screening instruments in detecting substance use disorders among prisoners.
    Peters RH; Greenbaum PE; Steinberg ML; Carter CR; Ortiz MM; Fry BC; Valle SK
    J Subst Abuse Treat; 2000 Jun; 18(4):349-58. PubMed ID: 10812308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric and discriminative properties of the Teen Addiction Severity Index (Brazilian Portuguese version).
    Sartes LM; De Micheli D; Souza-Formigoni ML
    Eur Child Adolesc Psychiatry; 2009 Nov; 18(11):653-61. PubMed ID: 19377864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative validity and clinical utility of an abuse-neglect interview for adolescents with conduct and substance use problems.
    Crowley TJ; Mikulich SK; Ehlers KM; Hall SK; Whitmore EA
    Am J Psychiatry; 2003 Aug; 160(8):1461-9. PubMed ID: 12900309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are clinical impressions of adolescent substance use accurate?
    Wilson CR; Sherritt L; Gates E; Knight JR
    Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for substance abuse in individuals with traumatic brain injury.
    Ashman TA; Schwartz ME; Cantor JB; Hibbard MR; Gordon WA
    Brain Inj; 2004 Feb; 18(2):191-202. PubMed ID: 14660230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance use problems and associated psychiatric symptoms among adolescents in primary care.
    Shrier LA; Harris SK; Kurland M; Knight JR
    Pediatrics; 2003 Jun; 111(6 Pt 1):e699-705. PubMed ID: 12777588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Michigan assessment-screening test for alcohol and drugs (MAST/AD): evaluation in a clinical sample.
    Westermeyer J; Yargic I; Thuras P
    Am J Addict; 2004; 13(2):151-62. PubMed ID: 15204666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site.
    Newcombe DA; Humeniuk RE; Ali R
    Drug Alcohol Rev; 2005 May; 24(3):217-26. PubMed ID: 16096125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SURPS French version validation in a Quebec adolescent population].
    Castonguay-Jolin L; Perrier-Ménard E; Castellanos-Ryan N; Parent S; Vitaro F; Tremblay RE; Garel P; Séguin JR; Conrod PJ
    Can J Psychiatry; 2013 Sep; 58(9):538-45. PubMed ID: 24099502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor structure and concurrent validity of the Drug Use Screening Inventory in a community adolescent sample.
    Siewert EA; Stallings MC; Hewitt JK
    Addict Behav; 2004 May; 29(3):627-38. PubMed ID: 15050681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of substance use measures in the detection of full and partial denial of drug use.
    Wooley CN; Rogers R; Fiduccia CE; Kelsey K
    Assessment; 2013 Dec; 20(6):670-80. PubMed ID: 22619394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.